This website is intended for healthcare professionals only.

Hospital Pharmacy Europe     Newsletter          

*** Editor’s Pick

Tapinarof cream effective for moderately severe plaque psoriasis
Tapinarof cream effective for moderately severe plaque psoriasis
Read more
RNA aptamer binds to COVID-19 spike protein preventing cellular entry
RNA aptamer binds to COVID-19 spike protein preventing cellular entry
Read more
Screening older black patients identifies elevated incidence of precursor condition for multiple myeloma
Screening older black patients identifies elevated incidence of precursor condition for multiple myeloma
Read more
Ivosidenib addition to azacitidine results in three-fold increase in overall survival in AML
Ivosidenib addition to azacitidine results in three-fold increase in overall survival in AML
Read more
Ethnic and socioeconomic disparities affect outcomes in ALL
Ethnic and socioeconomic disparities affect outcomes in ALL
Read more
Convolutional neural network diagnosis of ICH equivalent to radiologists
Convolutional neural network diagnosis of ICH equivalent to radiologists
Read more
Three doses of BNT162b2 able to neutralise Omicron variant
Three doses of BNT162b2 able to neutralise Omicron variant
Read more
Mosunetuzumab induces high and durable remission in patients with follicular lymphoma
Mosunetuzumab induces high and durable remission in patients with follicular lymphoma
Read more
The Domino effect: COVID-19 and the implication on CRC screening
The Domino effect: COVID-19 and the implication on CRC screening
Read more
Subclinical axillary lymphadenopathy due to COVID-19 vaccine seen on mammograms
Subclinical axillary lymphadenopathy due to COVID-19 vaccine seen on mammograms
Read more
Atrophic changes seen with MRI at autopsy could be marker for chronic traumatic encephalopathy
Atrophic changes seen with MRI at autopsy could be marker for chronic traumatic encephalopathy
Read more
Cancer clinical trial recruitment dropped by 60% during COVID
Cancer clinical trial recruitment dropped by 60% during COVID
Read more
Dupilumab reduces COVID-19 symptom burden in patients with atopic eczema
Dupilumab reduces COVID-19 symptom burden in patients with atopic eczema
Read more
RoActemra (tocilizumab) approved by EMA for use in severe COVID-19
RoActemra (tocilizumab) approved by EMA for use in severe COVID-19
Read more
mRNA-1273 vaccine associated with lower risk of COVID-19 outcomes than BNT162b
mRNA-1273 vaccine associated with lower risk of COVID-19 outcomes than BNT162b
Read more

Popular articles

Exacerbations reduced by dupilumab in COPD patients with type 2 inflammation
Biobank pilot to be launched by MHRA to better understand genetics and medicines safety
Government commits to easing pressure on NHS through commercial clinical trial investment





 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora